SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,732,784 | +13.6% | 22,544 | +7.3% | 0.02% | +15.0% |
| Q2 2023 | $2,405,607 | -23.8% | 21,006 | -8.2% | 0.02% | -28.6% |
| Q1 2023 | $3,155,067 | +9.5% | 22,891 | +2.9% | 0.03% | 0.0% |
| Q4 2022 | $2,881,730 | +15.4% | 22,239 | -1.5% | 0.03% | +7.7% |
| Q3 2022 | $2,497,000 | +48.6% | 22,589 | +0.8% | 0.03% | +62.5% |
| Q2 2022 | $1,680,000 | -3.8% | 22,418 | +0.3% | 0.02% | +14.3% |
| Q1 2022 | $1,747,000 | -5.0% | 22,361 | +9.5% | 0.01% | 0.0% |
| Q4 2021 | $1,838,000 | -3.7% | 20,415 | -1.1% | 0.01% | -12.5% |
| Q3 2021 | $1,909,000 | +19.8% | 20,643 | +0.7% | 0.02% | +23.1% |
| Q2 2021 | $1,594,000 | -1.1% | 20,509 | -5.1% | 0.01% | -7.1% |
| Q1 2021 | $1,611,000 | -55.8% | 21,615 | +1.1% | 0.01% | -57.6% |
| Q4 2020 | $3,646,000 | +15.2% | 21,386 | -5.1% | 0.03% | +6.5% |
| Q3 2020 | $3,166,000 | +14.7% | 22,543 | +31.0% | 0.03% | -20.5% |
| Q2 2020 | $2,760,000 | +64.5% | 17,211 | +0.3% | 0.04% | +34.5% |
| Q1 2020 | $1,678,000 | – | 17,154 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |